News

Adequan® in the News




APR, 2021
27
APR
Adequan® Renews Sponsorship of USEF Junior Hunter Championships for 2021
Lexington, KY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its title sponsorship of the USEF Junior Hunter National Championships for 2021 and the live stream of these competitions on USEF Network.

Adequan® Renews Sponsorship of USEF Junior Hunter Championships for 2021

Lexington, KY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its title sponsorship of the USEF Junior Hunter National Championships for 2021 and the live stream of these competitions on USEF Network.

The Adequan/USEF Junior Hunter National Championships consist of an East Coast and a West Coast final. The East Coast championship is scheduled for July 12-14 at Brandywine Horse Shows in Devon, Pa. The West Coast championship will be held at the Sonoma Horse Park in Petaluma, Calif., July 20-21.

“For more than 30 years, Adequan® has supported horses and riders of all levels,” says Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We are pleased to support these events featuring young riders on their way to becoming elite athletes.”

Horse-and-rider combinations at the championships compete at the 3’6” and 3’3” fence heights, completing a Classic Round, Under Saddle, and Handy Hunter phases on their quest for one of the most prestigious titles in the hunter discipline.

“The Adequan/USEF Junior Hunter Championships are always a highlight of the competition calendar,” said Bill Moroney, CEO of US Equestrian. “We’re so pleased to have Adequan’s continued support in making both the East Coast and West Coast championships a success year after year. We look forward to welcoming our youth hunter riders to the finals!”

Click here to learn more about the USEF Junior Hunter National Championships.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0606 04/2021


27
APR
Adequan® Renews Partnership with the USEA
Shirley, NY – The United States Eventing Association (USEA) is thrilled to announce the renewed partnership with longtime supporter American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final, and a Contributing Level Sponsor of the USEA American Eventing Championships (AEC).

Adequan® Renews Partnership with the USEA

Adequan® returns as The Official Joint Therapy Treatment of the USEA and Title Sponsor of the $60,000 Adequan® USEA Advanced Final.

Shirley, NY – The United States Eventing Association (USEA) is thrilled to announce the renewed partnership with longtime supporter American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final, and a Contributing Level Sponsor of the USEA American Eventing Championships (AEC).

“For over 15 years Adequan® has supported our horses and riders,” said USEA CEO Rob Burk. “Adequan® continues to invest in U.S. Eventing and they recently increased their support by offering unparalleled prize money in the Adequan® USEA Advanced Final. We are proud to have Adequan® as ‘The Official Joint Therapy of the USEA’ and we are very thankful for everything they do for the eventing community.”

As the Title Sponsor of the Adequan® USEA Advanced Final, Adequan® will generously provide $60,000 in prize money to the top finishers. The $60,000 Adequan® USEA Advanced Final will take place during the 2021 AEC on August 31 - September 5, 2021 at the Kentucky Horse Park in Lexington, Kentucky. As a Contributing Level Sponsor of the AEC, Adequan® will also provide prizes for every AEC division.

“We’re excited to continue partnering with USEA to help keep horses moving with Adequan® i.m.,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We’re looking forward to another season of competition and camaraderie.”

About the $60,000 Adequan® USEA Advanced Final
The $60,000 Adequan® USEA Advanced Final will take place at the 2021 USEA American Eventing Championships presented by Nutrena Feeds at the Kentucky Horse Park in Lexington, Kentucky, August 31 – September 5, 2021. Thanks to Adequan’s amazing support, the Adequan® USEA Advanced Final will bring together the country’s top rides to vie for $60,000 in prize money and the title of Adequan® Champion. To qualify for the $60,000 Adequan® USEA Advanced Final at the AEC in 2021, competitors will need to complete a minimum of two events without cross-country jump penalties at any USEA recognized Advanced horse trials, CCI4*-S, CCI4*-L , or CCI5*-L . The qualifying period for the 2021 AEC is May 25, 2020 through August 23, 2021. Click here to learn more about the $60,000 Adequan® USEA Advanced Final.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0633 04/2021


21
APR
US Equestrian Announces Adequan® as Title Sponsor of the New USEF Eventing Youth Team Challenge
Lexington, KY – US Equestrian is pleased to welcome Adequan® i.m. (polysulfated glycosaminoglycan) as the title sponsor of the Adequan® USEF Eventing Youth Team Challenge. The Youth Team Challenge is a new program for 2021 and is open to eventing athletes between the FEI ages of 14 and 25 at the CCI1*, CCI2*, and CCI3* levels. Participants will have the opportunity to experience competing as part of a team and representing their region.

US Equestrian Announces Adequan® as Title Sponsor of the New USEF Eventing Youth Team Challenge

Lexington, KY– US Equestrian is pleased to welcome Adequan® i.m. (polysulfated glycosaminoglycan) as the title sponsor of the Adequan® USEF Eventing Youth Team Challenge. The Youth Team Challenge is a new program for 2021 and is open to eventing athletes between the FEI ages of 14 and 25 at the CCI1*, CCI2*, and CCI3* levels. Participants will have the opportunity to experience competing as part of a team and representing their region.

“Adequan® has supported horses and riders for more than 30 years, and we are excited to continue that legacy,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “The athletes involved in this new program will shape the future of eventing and we look forward to moving ahead with them.”

The Adequan® USEF Eventing Youth Team Challenge is modeled after the FEI Eventing Nations Cup series and includes a series of competitions at events across the country. The series will conclude in the fall with the West Coast final at Galway Downs International in Temeculah, Calif., and the East Coast final at the Tryon International Three-Day Event in Mill Spring, N.C.

“Gaining team experience was integral in my ability to put forward the best performances to secure medals when it mattered most,” said Leslie Law, USEF Development and Emerging Athlete Coach. “We invite U.S. youth athletes to participate in the inaugural USEF Eventing Youth Team Challenge season and become a part of creating sustainable success on the world stage for the U.S.”

Learn more about the Adequan® USEF Eventing Youth Team Challenge here.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0601 02/2021


21
APR
Adequan® Continues as Official Joint Therapy of US Equestrian and Sponsor of U.S. Para Dressage Team, USEF Para Dressage National Championship
Lexington, KY – American Regent Animal Health, manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), will continue its longtime support of US Equestrian through the 2021 competition season. Adequan continues as the Official Joint Therapy of US Equestrian and remains the title sponsor of the USEF Para Dressage National Championship and the U.S. Para Dressage Team.

European Relaunch of Adequan® i.m. (polysulfated glycosaminoglycan) Progresses as Companies Mutually Agree to End Distribution Partnership

Lexington, KY– American Regent Animal Health, manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), will continue its longtime support of US Equestrian through the 2021 competition season. Adequan continues as the Official Joint Therapy of US Equestrian and remains the title sponsor of the USEF Para Dressage National Championship and the U.S. Para Dressage Team.

The Adequan U.S. Para Dressage Team is currently the top team on the FEI Para Dressage World Team Ranking List. This summer, they will travel to Tokyo to compete for gold at the 2021 Paralympics.

“With a 30-year legacy of supporting horses and riders, the Adequan® team understands the dedication required to reach this level,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We are pleased to contribute to the continued success of both individual riders and the Para Dressage Team.”

“We value American Regent’s continued support of US Equestrian and our elite athletes,” said Bill Moroney, CEO of US Equestrian. “We’re beyond excited about the future of our U.S. Para Dressage Team as they continue to raise the bar of excellence on the global stage. Adequan’s sponsorship of the team and of the Adequan/USEF Para Dressage National Championship ensures that our athletes have the opportunity to shine at home and in international competition.”

The 2021 Adequan/USEF Para Dressage National Championship will take place October 28-30 at the Tryon International Equestrian Center in Mill Spring, N.C., in conjunction with the Tryon Fall Dressage 3 CDI-W.

Click here to learn more about USEF Para Dressage Programs and the U.S. Para Dressage Team.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0605 04/2021


FEB, 2021
3
FEB
American Regent Animal Health Convenes Expert Panel to Provide Exclusive Insights on DJD
Shirley, NY – American Regent Animal Health, in partnership with EquiManagement, publishes insights from a panel discussion among eight veterinary practitioners to better understand how to help horses affected by degenerative joint disease (DJD). The panel comprises a cross-section of equine practitioners, including a recent graduate in private practice, leading imaging and lameness practitioners, and researchers and surgeons.

American Regent Animal Health Convenes Expert Panel to Provide Exclusive Insights on DJD

Shirley, NY – American Regent Animal Health, in partnership with EquiManagement, publishes insights from a panel discussion among eight veterinary practitioners to better understand how to help horses affected by degenerative joint disease (DJD). The panel comprises a cross-section of equine practitioners, including a recent graduate in private practice, leading imaging and lameness practitioners, and researchers and surgeons.

American Regent Animal Health, manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), enlisted EquiManagement to moderate the half-day conversation and curate the key takeaways, which address:

  • DJD incidence and diagnostic improvements
  • The horse owner’s role in recognizing DJD
  • Challenges with DJD supplements
  • DJD treatment options
  • Tips for clear communication between veterinarians and horse owners

Panelists agree more horses are being diagnosed with DJD. More horses are working later into their lives, making DJD a larger issue for the equine population, including horses ranging from elite competitors to “play day” mounts. The insights from the discussion may help practicing equine veterinarians successfully manage DJD in patients.

A few highlights from the expert comments:

  • "I do think in those young, hardworking, active athletes with that big push in their 3-year-old year that the incidence [of DJD] has probably gone up, especially in stifles and hocks." -Dr. Chris Kawcak
  • "First of all, one size does not fit all [in DJD treatment]. There's no cookbook [in DJD treatment]." -Dr. Rick Mitchell
  • "I try to talk to clients, telling them I feel it's a bigger bang for your buck if you go with the intramuscular Adequan [than unproven supplements]." -Dr. Robin Dabareiner

Click here to access the entirety of the panel’s exclusive insights.

INDICATIONS
For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For more information and Full Prescribing Information, www.adequan.com.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0600 02/2021



SEP, 2020
20
SEP
Roll Out the Red Carpet for the 2020 PATH Intl. Veterinarian Award Winners
Denver, CO – The Professional Association of Therapeutic Horsemanship (PATH Intl.) takes great pride in the exceptional veterinarians who serve at PATH Intl. Member Centers and the quality of life for the equines that partner with humans in equine-assisted activities and therapies (EAAT). PATH Intl. is pleased to announce the 2020 PATH Intl. Veterinarian Award in its 11 regions and the national award winner, sponsored by American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan).

For more information, contact:
Cher Smith, Communications Coordinator
(800) 369-7433, ext. 123
csmith@pathintl.org

Roll Out the Red Carpet for the 2020 PATH Intl. Veterinarian Award Winners

Denver, CO – The Professional Association of Therapeutic Horsemanship (PATH Intl.) takes great pride in the exceptional veterinarians who serve at PATH Intl. Member Centers and the quality of life for the equines that partner with humans in equine-assisted activities and therapies (EAAT). PATH Intl. is pleased to announce the 2020 PATH Intl. Veterinarian Award in its 11 regions and the national award winner, sponsored by American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan).

In previous years, PATH Intl. has celebrated the region winners at regional conferences and the national winners at the PATH Intl. Conference awards luncheon. Although this year the national conference and most of the regional conferences were postponed, the winners of these awards deserve recognition of their achievements. PATH Intl. and American Regent Animal Health offer their congratulations and accolades to these winners. In acknowledgement, American Regent Animal Health is providing five boxes of Adequan® i.m. to each regional recipient and 20 boxes of Adequan® i.m. to the national recipient.

(PATH Intl. Premier Accredited Centers are shown in italics.)

2020 PATH Intl. Regional Winners

Region 1
Veterinarian of the Year: Dr. Robert Baratt, High Hopes Therapeutic Riding, Inc., Old Lyme, CT

Region 1 includes the following states: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; and the Canadian provinces: New Brunswick, Newfoundland, Nova Scotia, Prince Edward Island and Quebec

Region 2
Veterinarian of the Year, Dr. Elden Klayman, Chariot Riders, Manchester, NJ

Region 2 includes the following states: Delaware, Maryland, New Jersey, New York, Pennsylvania and Washington, DC; and Scandinavia, Europe, Middle East

Region 3
Veterinarian of the Year, Dr. John Sanginario, EQUI-KIDS, Virginia Beach, VA

Region 3 includes North Carolina, South Carolina, Virginia and West Virginia

Region 4
Veterinarian of the Year, Dr. Sasha Hill, Fieldstone Farm Therapeutic Riding Center, Chagrin Falls, OH

Region 4 includes the following states: Indiana, Kentucky, Michigan, Ohio; and the Canadian Province of Ontario

Region 5
Veterinarian of the Year, Dr. Scott Swerdlin, Vinceremos Therapeutic Riding Center, Loxahatchee, FL

Region 5 includes Alabama, Florida, Georgia, Mississippi, Puerto Rico, Tennessee and Africa

Region 6
Veterinarian of the Year, Dr. Margaret Fauver, HorseSense, La Crosse, WI

Region 6 includes the following states: Minnesota, North Dakota, South Dakota and Wisconsin; and the Canadian Provinces of Manitoba and Saskatchewan

Region 7
Veterinarian of the Year, Dr. Ashley Wegmann, New Kingdom Trailriders, Sherrard, IL

Region 7 includes Illinois, Iowa, Kansas, Missouri and Nebraska

Region 8
Veterinarian of the Year, Dr. Kenton Arnold, Equest, Dallas, TX

Region 8 includes the following states: Arkansas, Louisiana, Oklahoma and Texas; and Mexico, Central America and South America

Region 9
Veterinarian of the Year, Dr. Cierra Dedeker,Ride for Joy Therapeutic Riding Program, Caldwell, ID

Region 9 includes the following states: Alaska, Idaho, Montana, Oregon and Washington State; and the Canadian provinces of Alberta and British Columbia

Region 10
Veterinarian of the Year, Dr. Judy Morris, StableStrides, Elbert, CO

Region 10 includes Arizona, Colorado, New Mexico, Utah and Wyoming

Region 11
Veterinarian of the Year, Dr. Kelly Zeytoonian, BOK Ranch, Woodside, CA

Region 11 includes the following states: California, Hawaii and Nevada; and Asia and Pacific

And the National Winner of the 2020 PATH Intl. Veterinarian of the Year is Ashley Wegmann.

Ashley Wegmann, who is described as hard-working and compassionate in all she does, takes time out of her busy schedule to volunteer her time to care for the horses at New Kingdom Trailriders in Sherrard, IL. She is currently a veterinarian at DeWitt Veterinary Clinic where she cares for animals of all shapes and sizes.

Congratulations to the 2020 PATH Intl. Veterinarian of the Year Award Winners!

-30-

About PATH Intl.:
The Professional Association of Therapeutic Horsemanship International® (PATH Intl.®) was formed in 1969 to promote safety and optimal outcomes in equine-assisted activities and therapies (EAAT) for individuals with special needs. At 881 member centers, more than 66,000 children and adults, including 6,200 veterans, may find improved health, wellness and a sense of pride, independence and fun through involvement with horses. Therapeutic horsemanship at member centers may include hippotherapy, equine-facilitated mental health, driving, interactive vaulting, trail riding, competition, ground work and stable management. Through a wide variety of educational resources, the association helps individuals start and maintain successful EAAT programs. There are nearly 62,500 volunteers, 5,011 instructors, 7,800 equines and thousands of contributors from all over the world helping people at PATH Intl. Member Centers.

About American Regent Animal Health:
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0506 9/2020



JUL, 2020
15
JUL
New Podcast Gives a Peek Behind the Barn Door of Legendary Equestrians
Melville, NY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), announces the launch of "Stories in Stride," a podcast that provides a glimpse into the lives and journeys of exceptional equestrians and equine professionals. Hosted by Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health, the podcast transcends disciplines to inspire and uplift everyone who shares a love of the horse.

New Podcast Gives a Peek Behind the Barn Door of Legendary Equestrians
During this time apart, “Stories in Stride” brings the horse community together through first-person accounts of success, disappointment, perseverance and hope.

Melville, NY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), announces the launch of "Stories in Stride," a podcast that provides a glimpse into the lives and journeys of exceptional equestrians and equine professionals. Hosted by Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health, the podcast transcends disciplines to inspire and uplift everyone who shares a love of the horse.

"The equine community is rich with amazing individuals whose stories are humbling, humorous and invigorating," Mann says. "It’s a privilege to bring them to light as a way of honoring history, addressing current challenges and highlighting an optimistic future we can shape together through our joint devotion to horses and equine sport."

Each "Stories in Stride" episode features a one-on-one conversation with an elite rider, trainer or veterinarian, including:

  • Boyd Martin, Olympic eventer
  • Bob Avila, Quarter Horse trainer
  • Rebecca Hart, Paralympic equestrian
  • JD Yates, performance horse trainer and team roper
  • Richard Mitchell, DVM, MRCVS, Dipl. ACVSMR, sport horse veterinarian and champion
  • And many more

The initial installments of "Stories in Stride" are available now, and new episodes will be released throughout the year. "Stories in Stride" can be accessed from Apple Podcasts, Google Podcasts and Spotify or your favorite podcast platform.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio under the American Regent brand. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0506 7/2020



JAN, 2020
06
JAN
Adequan® i.m. (polysulfated glycosaminoglycan) to Relaunch in Europe Following New Distributor Partnership Agreement
Shirley, NY– American Regent Animal Health, a division of American Regent, Inc., manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan) for horses announces a new partnership with Animalcare Group plc to relaunch Adequan i.m. in Europe.

Adequan® i.m. (polysulfated glycosaminoglycan) to Relaunch in Europe Following New Distributor Partnership Agreement

Shirley, NY – American Regent Animal Health, a division of American Regent, Inc., manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan) for horses announces a new partnership with Animalcare Group plc to relaunch Adequan i.m. in Europe.

Through the exclusive distribution agreement with American Regent Animal Health, Animalcare Group plc will work toward relaunching Adequan i.m. in Europe and selected markets following necessary regulatory approvals. Adequan i.m. has been unavailable for several years in Europe due to a supply issue that has now been fully resolved.

“We are excited to be working with American Regent Animal Health to bring this important product back to the market and look forward to relaunching it following necessary European regulatory review,” says Jenny Winter, CEO of Animalcare Group plc.

“The Animalcare partnership is an important first step in returning Adequan i.m. to veterinarians outside of North America,” says Andy Ferrigno, Head of Commercial Development for American Regent Animal Health. “We are working diligently with the team at Animalcare and regulatory officials toward a smooth relaunch in Europe, but we still have some work to do. A more definitive timeline for relaunch in Europe will be provided in the coming months.”

Adequan i.m. has been marketed in the United States for 30 years for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For more information and Full Prescribing Information, visit www.adequan.com.

About American Regent Animal Health
American Regent Animal Health, formerly known as Luitpold Animal Health, is a division of American Regent, Inc. American Regent Animal Health is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio under the American Regent brand. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

About Animalcare Group plc
Animalcare Group plc is a UK AIM listed veterinary sales and marketing organisation resulting from the merger of Animalcare and Ecuphar NV in July 2017. Animalcare operates in 32 countries in Europe and a further 16 worldwide. The company is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition. For more information, visit www.animalcaregroup.co.uk.

PP-AI-US-0326 12/2019



Let’s stay in touch.

Be the first to hear about important news and product information!
First, select the one that best describes you.
Then we'll take you to our sign-up page.

EQUINE VETERINARY
PROFESSIONAL
HORSE OWNER
AMERICAN REGENT ANIMAL HEALTH
About Us Our Brands
Animal Health Logo